0001209191-16-145038.txt : 20161005
0001209191-16-145038.hdr.sgml : 20161005
20161005165957
ACCESSION NUMBER: 0001209191-16-145038
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20161003
FILED AS OF DATE: 20161005
DATE AS OF CHANGE: 20161005
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Regulus Therapeutics Inc.
CENTRAL INDEX KEY: 0001505512
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 264738379
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-202-6300
MAIL ADDRESS:
STREET 1: 3545 JOHN HOPKINS COURT
STREET 2: SUITE 210
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: WRIGHT TIMOTHY MICHAEL
CENTRAL INDEX KEY: 0001686178
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35670
FILM NUMBER: 161923109
MAIL ADDRESS:
STREET 1: C/O REGULUS THERAPEUTICS INC.
STREET 2: 10614 SCIENCE CENTER DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2016-10-03
0
0001505512
Regulus Therapeutics Inc.
RGLS
0001686178
WRIGHT TIMOTHY MICHAEL
C/O REGULUS THERAPEUTICS INC.
10614 SCIENCE CENTER DRIVE
SAN DIEGO
CA
92121
0
1
0
0
Chief R & D Officer
Stock Option (Right to Buy)
3.30
2016-10-03
4
A
0
450000
0.00
A
2026-10-02
Common Stock
450000
450000
D
25% of the shares vest on October 3, 2017 and the remainder of the shares vest in equal installments on a monthly basis thereafter, such that
the option is fully vested on October 2, 2021.
Christopher Aker, Attorney in Fact
2016-10-05